Online Database of Chemicals from Around the World

L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
[CAS# 74163-81-8]

List of Suppliers
Capot Chemical Co., Ltd. China Inquire  
+86 (571) 8558-6718
+86 13336195806
capotchem@gmail.com
sales@capotchem.com
QQ chat
Chemical manufacturer
chemBlink standard supplier since 2006
AQCHEM, LLC USA Inquire  
+1 (925) 964-1221
sales@aqchem.com
Chemical manufacturer
chemBlink standard supplier since 2007
Simagchem Corporation China Inquire  
+86 13806087780
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2008
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Porphyrin Systems Germany Inquire  
+49 (40) 6466-5860
hombrecher@porphyrin-systems.de
Chemical manufacturer since 1999
chemBlink standard supplier since 2010
Creative Peptides USA Inquire  
+1 (631) 624-4882
info@creative-peptides.com
Chemical manufacturer
chemBlink standard supplier since 2010
Zhejiang Ideal Biotech Co., Ltd. China Inquire  
+86 (570) 433-6358
+86 13967002930
sales@idealbiotech.com
Chemical manufacturer since 2007
chemBlink standard supplier since 2014
Baiyin Chengze Chemical Technology Co., Ltd. China Inquire  
+86 (943) 853-5351
sales@chengzechem.com
QQ chat
Chemical manufacturer since 2014
chemBlink standard supplier since 2015
Complete supplier list of L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
Identification
Classification API >> Circulatory system medication >> Antihypertensive drug
Name L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
Molecular Structure CAS # 74163-81-8, L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
Protein Sequence X
Molecular Formula C10H11NO2
Molecular Weight 177.20
CAS Registry Number 74163-81-8
EC Number 616-058-0
SMILES C1[C@H](NCC2=CC=CC=C21)C(=O)O
Properties
Density 1.2±0.1 g/cm3 Calc.*
Melting point 300 ºC (Decomposes) (Expl.)
Boiling point 372.0±42.0 ºC 760 mmHg (Calc.)*
Flash point 178.8±27.9 ºC (Calc.)*
Index of refraction 1.577 (Calc.)*
Alpha -157.4 º (24 ºC) (Expl.)
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H315-H319-H335    Details
Precautionary Statements P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Eye irritationEye Irrit.2H319
Skin irritationSkin Irrit.2H315
Specific target organ toxicity - single exposureSTOT SE3H335
SDS Available
up Discovory and Applicatios
L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid is a chiral, partially hydrogenated heterocyclic carboxylic acid derived from the isoquinoline framework. It contains a bicyclic system composed of a benzene ring fused to a reduced pyridine ring, with a carboxylic acid substituent at the third position and an L-configuration at the stereogenic center. Compounds of the tetrahydroisoquinoline family have been known since investigations into isoquinoline reduction and related heterocycles carried out during the early development of classical organic chemistry. Studies of catalytic and chemical hydrogenation methods provided access to the tetrahydroisoquinoline core, from which carboxylated derivatives such as this compound were prepared through functional group manipulation and selective oxidation. Over time, stereoselective synthetic approaches enabled isolation of the optically pure L-enantiomer, reflecting the increased emphasis on chirality in chemical and biochemical research.

Interest in tetrahydroisoquinoline compounds increased as they were identified as structural motifs in a wide range of natural products. Alkaloids containing this scaffold were found in several plant families, especially those associated with traditional medicinal uses. This led to systematic investigation of synthetic analogues of such alkaloids to study their biological roles, metabolism, and potential therapeutic applications. The commercial development of chiral building blocks based on the tetrahydroisoquinoline skeleton followed, facilitating the incorporation of this motif into designed molecules. The carboxylic acid functionality at position three attracted attention because it permitted diverse derivatization and coupling reactions, making L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid a versatile intermediate in both academic and industrial laboratories.

The compound has been used extensively in synthetic chemistry, particularly in the preparation of chiral amides, esters, and peptide-like molecules. The carboxyl group enables formation of amide bonds with amines, giving access to complex nitrogen-containing structures. In addition, the tetrahydroisoquinoline core serves as a foundation for rigidified ligands, pharmacophores, and stereochemically defined fragments for structure–activity studies. For this reason, it has become a frequently used intermediate in the synthesis of analogues of natural tetrahydroisoquinoline alkaloids and other nitrogen heterocycles. Hydrogenation, oxidation, and substitution reactions can be selectively applied to the core while retaining the stereochemical integrity of the L-configuration, enabling preparation of derivatives with controlled geometric and electronic properties.

In biochemical research, the compound has been applied in studies related to amino acid analogues and peptide modification. The presence of a carboxyl group adjacent to a secondary amine allows it to mimic certain structural features of amino acids while introducing a bicyclic constraint. This has made it useful in designing modified peptides where conformational restriction is necessary to probe structure–function relationships. Incorporation into peptides can alter folding, receptor binding, and metabolic stability, providing a tool for investigating the interplay between rigidity and biological activity in peptide systems. Such applications have benefited from advances in coupling procedures and protecting group strategies that maintain the integrity of the tetrahydroisoquinoline ring.

Research into stereoselective synthesis enabled development of approaches to obtain the L-isomer by asymmetric hydrogenation, enzymatic resolution, or chiral auxiliary techniques. These methods improved accessibility and reproducibility, which allowed wider adoption of the compound in laboratory practice. The ability to prepare the compound in optically enriched form was important for its use in studying interactions with enzymes, receptors, and transport systems, where enantioselectivity plays a crucial role. As studies of chirality in medicinal and biological chemistry expanded, interest in compounds such as L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid increased correspondingly.

The compound has also been employed in methodological development in organic synthesis. It has served as a substrate in investigations of catalytic coupling, asymmetric transformation, and stereoretentive reactions. Because the bicyclic scaffold is sensitive to steric and electronic changes, it has functioned as a probe to characterize reaction pathways and selectivity trends. Additionally, its derivatives have been used to explore the impact of ring saturation, aromaticity, and substituent effects within nitrogen-containing polycyclic compounds.

Historically, the development and application of L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid reflect broader themes in heterocyclic chemistry, including the transition from early structural studies to modern stereoselective synthesis, and from small-scale academic preparations to applied research involving pharmaceuticals and biologically active compounds. Its continuing relevance arises from its dual identity as both a recognizable natural product–related motif and a flexible, functionally rich intermediate that supports the preparation of structurally diverse molecules for chemical, biological, and medicinal research.

References

2015. Synthesis of Optically Pure (R)- and (S)-Tetrahydroisoquinoline-1- and -3-Carboxylic Acids. Synthesis, 47(7).
DOI: 10.1055/s-0034-1380289

2019. Enantioseparations by High-Performance Liquid Chromatography Based on Chiral Ligand Exchange. Methods in Molecular Biology, 1985.
DOI: 10.1007/978-1-4939-9438-0_15
Market Analysis Reports
List of Reports Available for L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
Related Products
2,3,4,5-Tetrahydro-7-methoxy-1,4-benzothiazepine  (R)-1,2,3,4-Tetrahydro-3-isoquinolineacetic acid hydrochloride  1,2,3,4-Tetrahydroisoquinoline-5-carbonitrile  1,2,3,4-Tetrahydroisoquinoline-6-carbonitrile  1,2,3,4-Tetrahydroisoquinoline-7-carbonitrile hydrochloride  1,2,3,4-Tetrahydroisoquinoline-6-carbonitrile hydrochloride  1,2,3,4-Tetrahydroisoquinoline-3-carboxamide  1,2,3,4-Tetrahydroisoquinoline-4-carboxylic acid  1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid  1,2,3,4-Tetrahydro-6-isoquinolinecarboxylic acid  D-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid  (R)-1,2,3,4-Tetrahydro-1-isoquinolinecarboxylic acid  DL-1,2,3,4-Tetrahydroisoquinoline-1-carboxylic acid  (S)-1,2,3,4-Tetrahydroisoquinoline-1-carboxylic acid  1,2,3,4-Tetrahydro-4-isoquinolinecarboxylic acid ethyl ester  (R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid ethyl ester hydrochloride  (S)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid hydrobromide  (3S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid hydrochloride  1,2,3,4-Tetrahydroisoquinoline-6-carboxylic acid methyl ester  1,2,3,4-Tetrahydroisoquinoline-5-carboxylic acid methyl ester hydrochloride